Pituitary Tumor-Transforming 2 (PTTG2) Peptide
PTTG2
Reactivity: Human
Host: Synthetic
WB, BP
Catalog No. ABIN982469
Quick Overview for Pituitary Tumor-Transforming 2 (PTTG2) Peptide (ABIN982469)
Target
PTTG2
(Pituitary Tumor-Transforming 2 (PTTG2))
Origin
Human
Source
Synthetic
Application
Western Blotting (WB), Blocking Peptide (BP)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PTTG2 antibody (Catalog #: ARP50542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PTTG2 (Pituitary Tumor-Transforming 2 (PTTG2))
-
Background
-
PTTG2 belongs to the securin family. The N-terminal destruction box (D-box) acts as a recognition signal for degradation via the ubiquitin-proteasome pathway.
Alias Symbols: -
Protein Size: 191 -
Molecular Weight
- 21 kDa
-
Gene ID
- 10744
-
NCBI Accession
- NM_006607, NP_006598
Target
-
You are here:
